Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hartikainen

Showing results (91-100 of 142) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|September 18, 2014
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factorsAnja Rudolph, Roger L Milne, Thérèse Truong, et al.
JAMA Oncology|January 27, 2022
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes, Nasim Mavaddat, Leila Dorling, et al.
Breast Cancer Research : BCR|April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Cancers|June 2, 2021
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?JooYong Park, Ji-Yeob Choi, Jaesung Choi, et al.
Plos One|May 6, 2016
RAD51B in Familial Breast CancerLiisa M Pelttari, Sofia Khan, Mikko Vuorela, et al.
Scientific Reports|October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosisMaria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
Nature Communications|June 18, 2014
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyJingmei Li, Linda S Lindström, Jia N Foo, et al.
Research Square|February 24, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.
Cancer Medicine|July 4, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.
Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|September 18, 2014
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factorsAnja Rudolph, Roger L Milne, Thérèse Truong, et al.
JAMA Oncology|January 27, 2022
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes, Nasim Mavaddat, Leila Dorling, et al.
Breast Cancer Research : BCR|April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Cancers|June 2, 2021
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?JooYong Park, Ji-Yeob Choi, Jaesung Choi, et al.
Plos One|May 6, 2016
RAD51B in Familial Breast CancerLiisa M Pelttari, Sofia Khan, Mikko Vuorela, et al.
Scientific Reports|October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosisMaria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
Nature Communications|June 18, 2014
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyJingmei Li, Linda S Lindström, Jia N Foo, et al.
Research Square|February 24, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.
Cancer Medicine|July 4, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.
Pageof 15